Israel Englander Aerie Pharmaceuticals Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $480,043 - $1.15 Million	75,360 Added 175.75%	118,240 $1.79 Million
Q2 2022 Aug 15, 2022	SELL	$4.95 - $9.16 $2.92 Million - $5.4 Million	-589,297 Reduced 93.22%	42,880 $322,000
Q1 2022 May 16, 2022	SELL	$5.64 - $9.8 $2.17 Million - $3.78 Million	-385,488 Reduced 37.88%	632,177 $5.75 Million
Q4 2021 Feb 14, 2022	BUY	$7.02 - $13.33 $6.25 Million - $11.9 Million	889,851 Added 696.21%	1,017,665 $7.14 Million
Q3 2021 Nov 15, 2021	SELL	$11.32 - $16.63 $891,834 - $1.31 Million	-78,784 Reduced 38.13%	127,814 $1.46 Million
Q2 2021 Aug 16, 2021	BUY	$15.16 - $18.97 $2 Million - $2.5 Million	131,748 Added 176.02%	206,598 $3.31 Million
Q1 2021 May 17, 2021	SELL	$13.12 - $20.9 $1.09 Million - $1.73 Million	-82,965 Reduced 52.57%	74,850 $1.34 Million
Q4 2020 Feb 16, 2021	BUY	$9.12 - $14.49 $1.2 Million - $1.91 Million	131,591 Added 501.8%	157,815 $2.13 Million
Q3 2020 Nov 16, 2020	SELL	$10.46 - $14.46 $1.77 Million - $2.45 Million	-169,546 Reduced 86.6%	26,224 $309,000
Q2 2020 Aug 14, 2020	BUY	$12.0 - $16.13 $2.35 Million - $3.16 Million	195,770 New	195,770 $2.89 Million
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $2.34 Million - $3.32 Million	-132,183 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$18.41 - $28.0 $3.39 Million - $5.15 Million	-184,045 Reduced 58.2%	132,183 $2.54 Million
Q2 2019 Aug 15, 2019	BUY	$28.97 - $48.21 $5.08 Million - $8.45 Million	175,188 Added 124.21%	316,228 $9.35 Million
Q2 2019 Aug 14, 2019	SELL	$28.97 - $48.21 $10.3 Million - $17.1 Million	-353,902 Reduced 71.5%	141,040 $1.58 Million
Q1 2019 May 14, 2019	BUY	$36.32 - $49.25 $9.88 Million - $13.4 Million	272,042 Added 122.05%	494,942 $23.5 Million
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $4.46 Million - $8.11 Million	-135,055 Reduced 37.73%	222,900 $8.05 Million
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $5.54 Million - $7.28 Million	98,576 Added 38.0%	357,955 $22 Million
Q2 2018 Aug 14, 2018	SELL	$47.85 - $70.45 $6.17 Million - $9.09 Million	-129,012 Reduced 33.22%	259,379 $17.5 Million
Q1 2018 May 15, 2018	BUY	$51.15 - $61.0 $702,596 - $837,896	13,736 Added 3.67%	388,391 $21.1 Million
Q4 2017 Feb 14, 2018	BUY	$50.85 - $65.1 $5.59 Million - $7.15 Million	109,857 Added 41.49%	374,655 $22.4 Million
Q3 2017 Nov 14, 2017	BUY	$48.6 - $60.1 $12.9 Million - $15.9 Million	264,798	264,798 $12.9 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account